Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Effects of Indomethacin in Rabbit Renovascular Hypertension
Strong, Cameron G. , Romero, J. C.

Clinical Science | August 7, 2015 | Volume: 51 | Issue: s3 | Pages: 249s-251s

10.1042/cs051249s | PMID 1071620 Get It

1. Indomethacin inhibits prostaglandin synthesis and interferes with renin release; these effects were studied in rabbit renovascular hypertension. 2. Ten intravenous inject ons (3 mg day—1 kg—1 after two initial doses of 9 mg/kg) of indomethacin were given daily to ten normal rabbits, ten rabbits with two-kidney Goldblatt hypertension (2KH), and ten rabbits with one-kidney Goldblatt hypertension (1KH). Twelve appropriate control rabbits received diluent phosphate buffer without indomethacin. Plasma renin activity and plasma prostaglandin E2 were measured by radioimmunoassay. 3. In the normal group, indomethacin significantly decreased plasma prostaglandin E2 (1·15 to 0·2 ng/ml, sem 0·2; P < 0·01) and plasma renin activity (20 to 3 ng h—1 ml—1, sem 1, P < 0·01). Plasma creatinine increased slightly but the mean blood pressure was not significantly changed by indomethacin. 4. Six of ten rabbits with 2KH showed results similar to those in the normal rabbits. In four of ten rabbits in which development of 2KH was accompanied by increments in plasma renin activity (18 to 31·5 ng h—1 ml—1, sem 3 and 4 respectively; P < 0·01) and plasma prostaglandin E2 (1·2 to 3·4 ng/ml, sem 0·2 and 0·4 respectively; P < 0·05), treatment with indomethacin produced renal failure (plasma creatinine increasing to 7·6 mg/100 ml), oliguria, malignant hypertension (mean blood pressure, 168 mmHg, sem 7·7) and death within 5 days. 5. In 1KH, indomethacin decreased plasma renin activity and plasma prostaglandin E2, but caused increased mean blood pressure (102 to 121 mmHg, sem 4 and 6 respectively; P < 0·01) and decreased renal function (plasma creatinine 0·9 ± 0·04 to 3·5 ± 1 mg/100 ml, sem 0·04 and 1 respectively; P < 0·01). 6. Aggravation of hypertension was conditioned by pre-existing levels of renal function and, to a lesser extent, by plasma renin activities. 7. These results suggest that prostaglandins exert a protective effect on renal function in renovascular hypertension.
Epitaxial Relationships in Urolithiasis: The Calcium Oxalate Monohydrate—Hydroxyapatite System
Meyer, John L., Bergert, Jan H., Smith, L. H.

Clinical Science | August 7, 2015 | Volume: 49 | Issue: 5 | Pages: 369-374

10.1042/cs0490369 | PMID 1192695 Get It

Chemical kinetic data, complemented with scanning electron-microscope observations of the crystalline phase, show that seed crystals of hydroxyapatite have the ability to induce the growth of calcium oxalate monohydrate crystals epitaxially from a metastable supersaturated solution of calcium oxalate. The rate of growth of calcium oxalate crystals is dependent on the surface area of the seed material and follows a second-order rate law. It is suggested that there may be a causal relationship between the occurrence of apatite crystals in the urinary tract and the formation of both ‘pure’ and mixed urinary stones containing calcium oxalate. Under similar experimental conditions, however, seed crystals of calcium oxalate monohydrate appeared unable to induce epitaxially the growth of calcium phosphate crystals from a supersaturated calcium phosphate solution, indicating the absence of an epitaxial relationship between calcium oxalate monohydrate and the initially precipitating calcium phosphate phase(s).
Control of High and Low Blood Pressure in the Dog by Aortic and Sinus Nerves
Clément, D , Pelletier, L.Conrad, Shepherd, John T.

Clinical Science | August 7, 2015 | Volume: 48 | Issue: s2 | Pages: 257s-258s

10.1042/cs048257s | PMID 1077772 Get It

1. Changes in afferent activity in the aortic and sinus nerves with alterations of blood pressure were studied in anaesthetized dogs. Mean aortic blood pressure was changed from 220 to 50 mmHg by using a pressurized reservoir connected to the abdominal aorta. 2. The stimulus-response curve (defined by measuring the mean impulse frequency at various pressures) from both nerves was S-shaped; the curve for the aortic nerve was shifted to the right of the sinus nerve curve. 3. In the dog, the aortic arch baroreceptors act predominantly as an anti-hypertensive mechanism; at lower pressures, the major control occurs through the sinus baroreflex.
Metabolism of Renin Activity in Three Canine Models: Isolated Liver, Acute Hepatic Necrosis and Chronic Toxic Hepatitis
Strong, Cameron G. , Tapia, Hugo R., Hunt, James C.

Clinical Science | August 7, 2015 | Volume: 45 | Issue: s1 | Pages: 229s-233s

10.1042/cs045229s | PMID 4593568 Get It

1. Hepatic metabolism of renin activity was studied in seven normal dogs, twelve dogs with acute hepatic allograft rejection, five dogs with chronic toxic hepatitis and in seven isolated canine liver preparations. 2. Renin activity was measured by radioimmunoassay in hepatic arterial, portal venous, and hepatic venous plasma (PRA), in bile (BRA) and in perfusate (PsRA). 3. There was a significant gradient of PRA across the normal liver (P < 0.03) and of PsRA across the isolated liver (P < 0.05). 4. There was no significant PRA gradient across the liver of dogs with allograft rejection (acute hepatic necrosis). 5. Dogs with chronic toxic hepatitis showed decreased fractional extraction of PRA but otherwise their data were normal. 6. There was a significant difference between portal venous PRA (8.69 ±1.51 ng ml−1h−1) and hepatic arterial PRA (5.67±1.91 ng ml−1h−1) (P < 0.05). 7. BRA accounted for only 0.04% of hepatic extraction of PRA, suggesting that more important mechanisms for hepatic renin metabolism are binding or destruction of renin by the hepatic tissue.
The evolution of epilepsy surgery between 1991 and 2011 in nine major epilepsy centers across the United States, Germany, and Australia
Carlson, Chad , Cascino, Gregory D. , Dewar, Sandra , Engel, Jerome , Knowlton, Robert C. , McIntosh, Anne M. , O’Brien, Terence J. , Spencer, Dennis D. , Sperling, Michael R. , Bingaman, Bill, Doyle, Werner , French, Jacqueline A. , Jehi, Lara , Friedman, Daniel , Elger, Christian Erich , Kuzniecky, Ruben , Worrell, Gregory A. , González-Martínez, Jorge , Sperling, Michael R , French, Jacqueline

Epilepsia | August 7, 2015 | Volume: 56 | Issue: 10 | Pages: 1526-1533

10.1111/epi.13116 | PMID 26250432 Get It

Summary Objective Epilepsy surgery is the most effective treatment for select patients with drug‐resistant epilepsy. In this article, we aim to provide an accurate understanding of the current epidemiologic characteristics of this intervention, as this knowledge is critical for guiding educational, academic, and resource priorities. Methods We profile the practice of epilepsy surgery between 1991 and 2011 in nine major epilepsy surgery centers in the United States, Germany, and Australia. Clinical, imaging, surgical, and histopathologic data were derived from the surgical databases at various centers. Results Although five of the centers performed their highest number of surgeries for mesial temporal sclerosis ( MTS ) in 1991, and three had their highest number of MTS surgeries in 2001, only one center achieved its peak number of MTS surgeries in 2011. The most productive year for MTS surgeries varied then by center; overall, the nine centers surveyed performed 48% (95% confidence interval [CI] −27.3% to −67.4%) fewer such surgeries in 2011 compared to either 1991 or 2001, whichever was higher. There was a parallel increase in the performance of surgery for nonlesional epilepsy. Further analysis of 5/9 centers showed a yearly increase of 0.6 ± 0.07% in the performance of invasive electroencephalography ( EEG ) without subsequent resections. Overall, although MTS was the main surgical substrate in 1991 and 2001 (proportion of total surgeries in study centers ranging from 33.3% to 70.2%); it occupied only 33.6% of all resections in 2011 in the context of an overall stable total surgical volume. Significance These findings highlight the major aspects of the evolution of epilepsy surgery across the past two decades in a sample of well‐established epilepsy surgery centers, and the critical current challenges of this treatment option in addressing complex epilepsy cases requiring detailed evaluations. Possible causes and implications of these findings are discussed.
Acetaminophen knocks on death's door and receptor interacting protein 1 kinase answers
Guicciardi, Maria Eugenia , Jaeschke, Hartmut , Gores, Gregory J.

Hepatology | August 6, 2015 | Volume: 62 | Issue: 6 | Pages: 1664-1666

10.1002/hep.28107 | PMID 26251116 Get It

Enhancing Nurse-Resident Physician Partnerships
Benike, Linnea, Clark, J

Creative Nursing | August 6, 2015 | Volume: 21 | Issue: 3 | Pages: 150-155

10.1891/1078-4535.21.3.150 | PMID 26376573 Get It

Literature has long suggested that collaboration and interprofessional communication are associated with improved provider satisfaction, patient satisfaction, and the provision of individualized care. More recent literature has documented the favorable influence of a collaborative culture on patient outcomes. In response to the growing need for enhanced nurse–physician partnership and recognition of its impact on the patient experience, nurses are designing unit-based programs to bring the two professions together for opportunities to enhance partnership. This article discusses two approaches to enhancing nurse–resident physician partnership introduced by Benike and Clark (2013) and identifies common elements that were critical to the programs ‘success.
Phenotypic Characterization of Mice Carrying Homozygous Deletion of KLF11, a Gene in Which Mutations Cause Human Neonatal and MODY VII Diabetes
Mathison, Angela , Escande, Carlos , Calvo, Ézéquiel, Seo, Seungmae , White, Thomas A. , Salmonson, Ann, Faubion, William A. , Buttar, Navtej , Lomberk, Gwen , Chini, Eduardo N. , White, Thomas, Urrutia, Raúl , Iovanna, Juan , Lomberk, Gwen L , Mathison, Angela J

Endocrinology | August 6, 2015 | Volume: 156 | Issue: 10 | Pages: 3581-3595

10.1210/en.2015-1145 | PMID 26248217 Get It

We have previously shown that amino acid changes in the human Kruppel-Like Factor (KLF) 11 protein is associated with the development of maturity onset diabetes of the young VII, whereas complete inactivation of this pathway by the −331 human insulin mutation causes neonatal diabetes mellitus. Here, we report that Klf11−/− mice have decreased circulating insulin levels, alterations in the control of blood glucose and body weight, as well as serum dyslipidemia, but do not develop diabetes. Functional assays using ex vivo liver tissue sections demonstrate that Klf11−/− mice display increased insulin sensitivity. Genome-wide experiments validated by pathway-specific quantitative PCR arrays reveal that the Klf11−/− phenotype associates to alterations in the regulation of gene networks involved in lipid metabolism, in particular those regulated by peroxisome proliferator-activated receptor-γ. Combined, these results demonstrate that the major phenotype given by the whole-body deletion of Klf11 in mouse is not diabetes but increased insulin sensitivity, likely due to altered transcriptional regulation in target tissues. The absence of diabetes in the Klf11−/− mouse either indicates an interspecies difference for the role of this transcription factor in metabolic homeostasis between mouse and humans, or potentially highlights the fact that other molecular factors can compensate for its absence. Nevertheless, the data of this study, gathered at the whole-organism level, further support a role for KLF11 in metabolic processes like insulin sensitivity, which regulation is critical in several forms of diabetes.
Genetic susceptibility to hepatitis E viral infection: An enigmatic virus gives up a secret
Ditah, Ivo, Charlton, Michael

Hepatology | August 6, 2015 | Volume: 62 | Issue: 5 | Pages: 1337-1338

10.1002/hep.28106 | PMID 26250990 Get It

Evolution: IMiDs to PPMs, revolution in DLBCL?
Nowakowski, Grzegorz S.

Blood | August 6, 2015 | Volume: 126 | Issue: 6 | Pages: 698-700

10.1182/blood-2015-06-649483 | PMID 26251224 Get It